is glp-1 tirzepatide Decoding Weight Loss Medications Personalized Compounded Tirzepatide Treatment

Semaglutide GLP-1 does not typically eliminate hunger immediately after the first dose

Although patients on semaglutide, the drug in Ozempic and Wegovy, lost on average 10 percent of their body weight, a third lost less than 5 percent in one clinical trial

This matters enormously for people on titration protocols

As the WL achieved with the novel obesity pharmacotherapies approaches that of bariatric surgery, we will need to assess whether long-term complications observed after bariatric surgery such as increased risk of osteoporosis, fractures, macro- and micronutrient deficiencies as well as self-harm behaviours will also be present with pharmacotherapy [112, 113]

Stable Digestion: Normal bowel habits without significant constipation or diarrhea

Chen Q, Miller LJ, and Dong M